Edward Lang Jr

Chief Business Officer at Gyroscope Therapeutics

Edward Lang is Chief Business Officer at Gyroscope. Ed brings more than 16 years of communication, public affairs and patient advocacy relations experience in the biotechnology industry. Previously, Ed has served as the primary media strategist and spokesperson for large and small biotech companies including Genentech, Roche and Juno Therapeutics.

Over his career Ed helped to bring more than 12 new medicines to patients around the world in the fields of oncology, ophthalmology, immunology and rare disease.


Org chart


Teams


Offices

This person is not in any offices


Gyroscope Therapeutics

Gyroscope Therapeutics is a clinical-stage retinal gene therapy company developing gene therapy beyond rare diseases to treat a leading cause of blindness, dry age-related macular degeneration (AMD).


Industries

Employees

51-200

Links